好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Randomized, Double-Blind, Placebo-Controlled, 24-Week, Phase 2b Outcomes Study of 3 Different Doses of Encenicline or Placebo in Subjects With Mild to Moderate Probable Alzheimer’s Disease
Aging, Dementia, and Behavioral Neurology
(-)
100
Authors/Disclosures
Hans J. Moebius, MD, PhD, FAAN
PRESENTER 		Dr. Moebius has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Athira Pharma, Inc.. Dr. Moebius has stock in Athira Pharma, Inc..
No disclosure on file
No disclosure on file
Dana C. Hilt, MD (Frequency Therapeutics) Dr. Hilt has received personal compensation for serving as an employee of Actinogen Medical. Dr. Hilt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brenig Therapeutics.